Limitations of our study include lack of evaluation in the orthotopic prostate environment, which can be challenging due to early ureteral obstruction and difficulty with monitoring tumor growth, and lack of evaluation of the effects of myeloid KLF4 deletion using additional prostate cancer models. This evidence concerns the gene KLF4 and prostate cancer.